Overview
- A study published in BMJ Open analyzed data from 344,628 adults over 50 diagnosed with Alzheimer’s between 2006 and 2021, comparing them to an equal number without the disease.
- The findings suggest individuals with HSV-1 infection have an 80% higher risk of developing Alzheimer’s compared to those without the virus.
- Those treated with antiviral medications for HSV-1 showed a 17% lower risk of Alzheimer’s than untreated individuals, highlighting potential protective effects.
- Experts caution that the study is observational, based on insurance records, and does not establish a direct causal relationship between HSV-1 and Alzheimer’s.
- HSV-1’s potential role in Alzheimer’s may involve brain inflammation and tau protein changes, but further research is needed to confirm mechanisms and evaluate antiviral therapies.